Sepsis is a surprisingly common life-threatening illness in U.S. hospitals, contributing to as many as half of all deaths there, according to a 2014 study by the Journal of the American Medical Association. Around 250,000 Americans die each year from the condition, the Centers for Disease Control and Prevention has reported. For its innovative blood-filtering device designed to prevent deaths from sepsis, the new startup GoodSIRS earned the $25,000 grand prize last night through the first-ever MIT Sloan Healthcare Innovations Prize. Sepsis is caused when a blood infection triggers an increase in molecules called cytokines, which drive the systemic inflammatory response syndrome (SIRS) that causes organ failure. The GoodSIRS team — from Boston Children’s Hospital, MIT, and Harvard Business
来源(Source From): http://news.mit.edu/2016/sepsis-curing-device-wins-mit-sloan-healthcare-innovations-prize-0226